Scar endometriosis is uncommon and defined as the presence of ectopic endometrial glands in abdominal soft tissues after a gynecological operation. Malignant transformation has been reported but remains rare. Carcinogenesis occurs in ectopic endometrial tissue with repeated hormone stimulation during the menstrual cycle. We present a case of clear cell carcinoma directly arising from scar endometriosis after a cesarean section and review all 16 cases reported.
Introduction
E ndometriosis indicates functional endometrial tissues outside the uterus. It may be identified in abdominal scars after gynecological surgery and can cause pain during menstrual periods and abdominal swelling. Malignant transformation is extremely rare.
Here, we present a 46-year-old patient with clear cell carcinoma (CCC) in an abdominal scar after a cesarean section.
Case report
Our patient was a gravida 2, para 1 with irregular menstrual periods and had undergone a cesarean section 18 years previously. She visited the plastic surgery department and complained about a tender mass with ulceration in the right lower abdominal wall for 2 months. Physical examination revealed 2 firm, immobile masses over the lower abdomen. The right mass was erythematous with central ulceration. Computed tomography revealed 7.0 and 9.5 cm lobulated tumors with focal cystic changes, located in the subcutaneous layer and extending into the rectus abdominis muscle. The patient underwent wide local excision.
The tumors excised from the right and left sides of the abdomen measured 7.0 cm × 5.3 cm × 4.0 cm and 6.3 cm × 3.2 cm × 2.5 cm, respectively. The overlying skin was ulcerated. On sectioning, the tumors were lobulated with an infiltrating border. Focal myxoid changes and transformation from endometriosis is estimated to be up to 1%. To date, only 22 cases of carcinoma arising from scar endometriosis have been reported. Among these cases, the development rate of CCC was approximately 77.3% (17/22), followed by endometrioid carcinoma (13.6%, 3/22) and serous carcinoma (0.09%, 2/22). Notably, CCC is the most common malignancy arising from extragonadal endometriosis. Therefore, we analyzed all 17 cases of CCC associated with scar endometriosis, including our case, and the details are shown in Table 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Sixteen of the 17 patients (94.1%) had a surgical history of cesarean section, and the remaining one patient had undergone a laparoscopic cystectomy. Because cesarean section is the most common obstetric surgery in reproductive-aged women and may provide a long period to allow carcinogenesis, the duration from the time of surgery to CCC diagnosis varied from 9 to 30 years (mean, 17.9 years) in these cases. Most cases were originally diagnosed as a subcutaneous mass, including a simple cyst, chronic abscess and others. Only three patients had received surgery for abdominal endometriosis and local recurrence was then suspected. However, none was initially diagnosed with a malignancy.
When diagnosing a malignancy from preexisting endometriosis, the presence of benign endometrial tissue in the tumor is a key point. Histopathology revealed differentiating CCC in all cases; however, preexisting benign endometrial glands were identified in only 11 cases (64.7%, 11/17). In our case, benign endometrial tissue was observed in only a small focus from the periphery of the malignant lesion, which indicated an old hemorrhage, and was more fibrotic on gross inspection. Thus, examination of multiple sections is required and highly recommended to establish this diagnosis.
All 17 patients underwent local excision, of whom ten underwent bilateral salpingo-oophorectomy and total hysterectomy (58.8%). However, no malignant lesion was observed on uterine and ovary resection. After excising the primary tumor, adjuvant therapies with chemotherapy, radiotherapy, or a combination were administered in 16 cases. The mean follow-up duration was 14.7 months. Local recurrence in one case was attributed to a positive resection margin. Five patients died of disease (29.4%), mostly due to extensive, generalized metastasis. Particularly, three of these five cases had involvement of inguinal and pelvic lymph nodes at the initial presentation. In our case, local excision was performed; however, the basal resection margin and rectus abdominis muscle were involved by tumor cells. An additional radiotherapy session was subsequently conducted for local control. Abdominal total hysterectomy and bilateral salpingo-oophorectomy were also suggested to determine the possibility of a coexisting malignancy. Because of the rarity of this disease, it is difficult to establish a standard treatment protocol, and no appropriate disease staging system is applicable. Most cases were treated as primary ovarian CCC with metastasis, and radical surgery with adjuvant chemo-or radiotherapy was performed.
CCC arising from scar endometriosis remains a rare phenomenon. The most affected population is women who undergone operations such as myomectomy or cesarean section that may introduce ectopic endometrial tissues into abdominal soft tissues. No definite treatment guidelines are presently available because of disease rarity. However, wide local excision and radical surgery with total hysterectomy and bilateral salpingo-oophorectomy are indicated in most cases if coexisting malignancy can be excluded. Pelvic and inguinal lymph node dissection is also recommended to predict distant metastasis and a poor outcome if any positive node is present. Adjuvant chemo-or radiotherapy may provide some benefits in local control and metastatic diseases; however, the effect on prognosis, including the overall survival rate or progression-free survival, remains unclear.
We recommend that patients with a history of gynecological surgeries complicated by scar endometriosis undergo total wide excision with a free surgical resection margin, if possible. Furthermore, the possibility of malignant transformation should be considered and close follow-up is needed.
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